期刊文献+

微管蛋白秋水仙碱位点抑制剂研究进展 被引量:1

Recent Development of Colchicine Binding Site Inhibitors
原文传递
导出
摘要 微管蛋白是细胞骨架的主要成分,参与了细胞过程的许多环节。秋水仙碱位点抑制剂(CSIs)是一类重要的微管蛋白聚合抑制剂。目前已经有许多CSIs作为抗肿瘤药物被发现或设计、合成,并取得了很大的进展。本研究主要就CSIs的作用机制、共同结构特征以及各种类型CSIs的构效关系作一综述。 Microtubules are cytoskeletal components which play important roles in a number of cellular processes.Colchicine binding site inhibitors(CSIs) is one of the major classes of tubulin polymerization inhibitors.Many CSIs have been discovered,designed or synthesized as anticancer agents in the past several years and great progress has been made.We discuss the insights gained so far relevant to the mechanism of CSIs and their common structures.The recent development of CSIs with their biological activity and structure-activity relationship is also reviewed.
出处 《中国现代应用药学》 CAS CSCD 北大核心 2011年第9期824-830,共7页 Chinese Journal of Modern Applied Pharmacy
关键词 微管蛋白 秋水仙碱位点 抑制剂 构效关系 抗肿瘤 microtubules colchicine binding site inhibitor structure-activity relationship anticancer
  • 相关文献

参考文献56

  • 1MITCHISON T, KIRSCHNE M. Dynamic instability of microtubule growth [J]. Nature, 1984, 312(5991): 237-242.
  • 2MARGOLIS R L, WILSON L. Opposite end assembly and disassembly of microtubules at steady state in vitro [J]. Cell, 1978, 13(1) : 1-8.
  • 3HOWARD J, HYMAN A A. Dynamics and mechanics of the microtubule plus end [J]. Nature, 2003, 422(6933): 753-758.
  • 4NOGALE E, WOLF S G, DOWNING K H. Structure of the alpha beta tubulin dimer by electron crystallography [J]. Nature, 1998, 391(6663): 199-203.
  • 5LOWE J, LI H, DOWNING K H, et al. Refined structure of alpha beta-tubulin at 3.5 A resolution [J]. J Mol Biol, 2001, 313(5): 1045-1057.
  • 6RAVELLI R B, GIGANT B, CURMI P A, et al. Insight into tubulin regulation from a complex with colchicine and a stathmin-like domain [J]. Nature, 2004, 428(6979): 198-202.
  • 7NGUYEN T L, MCGRATH C, HERMONE A R, et al. A common pharmacophore for a diverse set of colchicine site inhibitors using a structure-based approach [J]. J Med Chem, 2005, 48(19): 6107-6116.
  • 8李耀武,周有骏,朱驹,郑灿辉,陈军,唐辉,栗亚男.秋水仙碱位点抑制剂的结构特征研究[J].药学实践杂志,2007,25(6):372-375. 被引量:6
  • 9BROSSI A, YEH H J, CHRZANOWSKA M, et al. Colchicine and its analogues. Recent findings [J]. J Med Res Rev, 1988, 8(1): 77-94.
  • 10ANDREU J M, TIMASHEFF S N. Conformational states of tubulin liganded to colehicine, tropolone methyl ether, and podophyllotoxin [J]. Biochemistry, 1982, 21 (25): 6465-6467.

二级参考文献15

  • 1Downing KH, Nogales E. Tubulin structure: insights into microtuhule properties and functions [ J ]. Curr Opin Struct Biol, 1998, 8(6) :785.
  • 2Tron, GC, Pirali T, Sorba G, et al. Medicinal chemistry of combretastatin A4: present and future directions[J]. J Med Chem, 2006, 49( 11 ) :3033.
  • 3Ozawa Y, Sugi NH, Nagasu T, et al. E7070, a novel sulfonamide agent with potent antitumor activity in vitro and in vivo[ J], Eur J Cancer, 2001, 37(17) :2275.
  • 4Wipf P, Reeves JT, Day BW. Chemistry and Biology of Curacin A[J]. Curr Pharm Design, 2004, 10(21):1417.
  • 5Nguyen TL, McGrath C, Hermone AR, et al. A common pharmacophore for a diverse set of colchicine site inhibitors using a structure-based approach [J]. J Med Chem, 2005, 48( 19): 6107.
  • 6Gaukroger K, Hadfield JA, Lawrence NJ, et al. Structural re quirements for the interaction of combretastatins with tubulin how important is the trimethoxy unit[J]. Org Binmol Chem 2003, 1 ( 6 ) :3033.
  • 7Hamel E, Lin CM, Flynn E, et al. Interactions of 2-Methoxyestradiol, an endogenous mammalian metabolite, with unpo- lymerized tubulin and with tubulin pnlymers[J]. Biochemistry, 1996, 35(4) :1304.
  • 8Ducki S, Mackenzie G, Lawrence N J, et al. Quantitative structure-activity relationship (5D-QSAR) study of combretastatin- like analogues as inhibitors of tubulin assembly [J]. J Med Chem, 2005, 48(2) :457.
  • 9Pettit GR, Rhodes MR, Herald DL, et al. Synthesis and evaluation of structural modifications of (Z) - and (E)-combretastatin A-4[J]. J Med Chem, 2005, 48(12) :4087.
  • 10Pettit GR, Toki B, Herald DL, et al. Synthesis of phenstatin phosphate[J]. J Med Chem, 1998, 41(10):1688.

共引文献5

同被引文献20

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部